The DRUGMATRIX assay being referred to here is specifically for the Adenosine A1 receptor's radioligand binding, in which the ligand used is DPCPX. This particular receptor has been assigned as a homologous single protein target for the assay. The CHO cell type has been used as the assay cell type, with the membrane serving as the assay subcellular fraction. As for the assay test type, it falls under in vitro testing methods. And finally, the assay type description is binding, which refers to the specific mechanism by which the Adenosine A1 receptor's radioligand binding is being measured in this particular assay. Does this molecule work well for this assay?